•
Dec 31, 2021

Clorox Q2 2022 Earnings Report

Clorox's financial performance declined due to decreased net sales and gross margin, impacted by higher manufacturing & logistics and commodity costs.

Key Takeaways

Clorox reported a decline in net sales by 8% to $1.7 billion, driven by a 10-point decline in volume, though favorable price mix contributed 2 points. Gross margin decreased significantly by 1240 basis points to 33%. Diluted EPS decreased by 72% to $0.56, and adjusted EPS declined by 67% to $0.66.

Net sales decreased by 8% to $1.7 billion, reflecting a 10-point decline in volume and 2 points of favorable price mix.

Gross margin decreased to 33% from 45% due to higher manufacturing & logistics and commodity costs.

Diluted EPS decreased by 72% to $0.56, primarily driven by lower gross margin and lower net sales.

Adjusted EPS decreased by 67% to $0.66, excluding investments in long-term strategic digital capabilities and productivity enhancements.

Total Revenue
$1.69B
Previous year: $1.84B
-8.2%
EPS
$0.66
Previous year: $2.03
-67.5%
Organic Sales Growth
-8%
Previous year: 26%
-130.8%
Gross Profit
$558M
Previous year: $497M
+12.3%
Cash and Equivalents
$192M
Previous year: $273M
-29.7%
Free Cash Flow
$124M
Previous year: $164M
-24.4%
Total Assets
$6.19B
Previous year: $6.37B
-2.9%

Clorox

Clorox

Clorox Revenue by Segment

Forward Guidance

The company updated its fiscal year 2022 outlook, projecting a net sales decline of 1% to 4% and diluted EPS between $3.80 and $4.05.

Positive Outlook

  • Company expects sales to return to its long-term sales growth target of 3% to 5% by the fourth quarter.
  • Advertising and sales promotion spending at about 10% of net sales, reflecting the company’s ongoing commitment to invest behind its brands.
  • Selling & administrative expenses at about 15% of net sales, reflecting about 1 point of impact from the company’s strategic investments in digital capabilities and productivity enhancements.
  • Company is driving cost savings and pricing to mitigate inflationary headwinds.
  • Company is investing in innovation, its brands and strategic digital capabilities.

Challenges Ahead

  • Net sales decline of 1% to 4% (organic sales decline of 1% to 4%).
  • Gross margin decline of about 750 basis points, primarily due to higher than previously anticipated commodity and manufacturing & logistics costs.
  • Diluted EPS between $3.80 and $4.05, or a decrease between 32% and 27%, respectively.
  • Adjusted EPS between $4.25 and $4.50, or a decrease between 41% and 38% respectively.
  • Cost pressures will continue through fiscal year 2022

Revenue & Expenses

Visualization of income flow from segment revenue to net income